forest8kdec09.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT
REPORT
__________________________________________
Pursuant
to Section 13 or 15 (d) of
The
Securities Exchange Act of 1934
December
7, 2009
Date of
report (date of earliest event reported)
FOREST
LABORATORIES, INC.
(Exact
name of registrant as specified in its charter)
|
Delaware
(State
or other jurisdiction of incorporation or organization)
|
1-5438
(Commission
File Number)
|
11-1798614
(I.R.S.
Employer Identification Number)
|
|
|
|
|
|
909
Third Avenue
New
York, New York
(Address
of principal executive offices)
|
|
10022-4731
(Zip
code)
|
(212)
421-7850
(Registrant's telephone number,
including area code)
None
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
5.02. Departure of
Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain
Officers
On
December 7, 2009, the Board of Directors of Forest Laboratories, Inc. increased
the number of members constituting the Board from eight to nine and appointed
Peter J. Zimetbaum, M.D. to serve as a Director. Dr. Zimetbaum is
currently Director of Clinical Cardiology at the Beth Israel Deaconess Medical
Center in Boston and an Associate Professor of Medicine at the Harvard School of
Medicine in Boston.
Item
9.01. Financial
Statements and Exhibits
(c) Exhibit 99 Press
release of Forest Laboratories, Inc. dated December 9, 2009.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
Date: December
9, 2009
Forest Laboratories,
Inc.
(Registrant)
/s/ Francis I. Perier,
Jr.
Francis
I. Perier, Jr.
Senior
Vice President - Finance and
Chief
Financial Officer